Beta Drugs Ltd Financial Statement - Beta Drugs Ltd Balance Sheet | Research 360 by Motilal Oswal
15:40 Apr 19

Beta Drugs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1398.50
+18.55 (+1.34%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Beta Drugs Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1398.50
+18.55 (+1.34%)
15:40 Apr 19
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

6/100
Expensive Valuation

Technical

67/100
Technically Moderately Bullish

Strength

5

Weakness

1

Opportunity

2

Threats

0

24.99 %

ROE %

15.48 %

ROA %

31.95

EPS

127.82

BVPS

13.52 %

Net Profit Margin

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales
65.93 90.81 116.12 183.84 227.11
Operating Expenses +
54.13 72.89 91.38 141.14 173.99
Raw Material
37.1 45.21 60.55 96.21 110.4
Increase Decrease in Cost
-3.67 -0.85 -1.77 -1.75 -4.71
Other Manufacturing Expense
7.95 10.33 13.4 17.78 24.29
Employee Cost
5.27 9.46 10.88 15.91 22.7
Miscellaneous Expenses
7.48 8.74 8.32 12.99 21.31
Operating Profit
11.8 17.92 24.74 42.7 53.12
Other Income
0.37 0.41 0.5 0.76 0.75
Depreciation
2.84 3.76 6.87 7.25 10.41
Interest
1.43 2.59 2.42 1.9 2.41
Profit before tax and exceptio..
7.91 11.97 15.95 34.3 41.06
Exceptional Items
0 0 0 0 0
PBT
7.91 11.97 15.95 34.3 41.06
Provision for Taxation
-0.13 2.56 4.23 9.47 10.34
Net Profit
8.04 9.42 11.72 24.83 30.72
NET Profit after MI
8.04 9.42 11.72 24.83 30.72
EPS
9.3 9.93 12.2 25.82 31.95
Operating Profit Margin (%)
17.9 19.73 21.31 23.23 23.39
Net Profit Margin (%)
12.19 10.37 10.09 13.51 13.53

ShareHolding

All Data in Percentage (%)

Dec 23 Sep 23 Jun 23 Mar 23 Dec 22
Promoter 66.70 66.70 66.70 66.70 66.70
FII 0.30 0.30 0.30 0.30 0.30
MF - - - - -
Public 33.00 32.90 32.90 32.90 33.00
Others 0.00 0.10 0.10 0.10 0.00
Shareholder Shares Holding %

Download Our App On: